干细胞衍生胰岛细胞药物的质量风险管理及评价考虑

刘丹, 卢加琪, 尹慧芳, 韦薇

Quality risk management and considerations on evaluation of stem cell-derived pancreatic islet cell medicinal products

LIU Dan, LU Jia-qi, YIN Hui-fang, WEI Wei

中国新药杂志 . 2025, (24): 2598 -2604 . DOI: 10.20251/j.cnki.1003-3734.2025.24.004